Fibromyalgia Clinical Trials 2024

What are the top hospitals conducting fibromyalgia research?

Fibromyalgia, a complex and often misunderstood condition characterized by chronic pain and fatigue, is the focus of pioneering clinical trials at several top hospitals. The University of Florida in Gainesville leads the way with four ongoing trials aimed at unraveling the mysteries of fibromyalgia. Since initiating their first trial in 2009, they have been dedicated to finding effective treatments for this debilitating condition. Similarly committed to advancing fibromyalgia research, the University of Michigan in Ann Arbor currently has two active trials running alongside four previously conducted studies dating back to 2005.

In Charlestown's Massachusetts General Hospital, another prominent medical institution delves into understanding fibromyalgia through two ongoing clinical trials. Despite having a shorter history with this condition compared to others on the list – their first recorded trial took place in 2013 – their contributions are invaluable as they work towards improving quality-of-life for those affected.

Notably, Cincinnati Children's Hospital Medical Center plays an essential role by conducting two active fibromyalgia trials while adding depth through five previous investigations since launching its inaugural study in 2004. Meanwhile, all the way across the Pacific Ocean at Kona Research Center located in Kailua takes part too by contributing valuable insights through their contemporary approach as they recently initiated recording data from their first-ever trial specifically focusing on fibromyalgia just last year (2020).

These top hospitals serve as beacons of hope for individuals living with fibromyalgia and underline humanity's commitment to unraveling its intricate complexities and providing relief for those who suffer from it daily. Through these dedicated efforts within various locations throughout the country—including Florida, Michigan, Massachusetts Ohio—and even reaching out across oceans like Hawaii—progress is being made inch-by-inch toward alleviating pain and restoring normalcy for countless individuals impacted by this enigmatic disorder

Which are the best cities for fibromyalgia clinical trials?

In the realm of fibromyalgia clinical trials, several cities take the lead in research and development. Gainesville, Florida is at the forefront with 5 active trials focusing on interventions like Paced Auditory Serial Addition task (PASAT), Breathing and Attention Training (BAT), and Medical Cannabis. Ann Arbor, Michigan follows closely behind with 4 ongoing studies exploring treatments such as Psychotherapy and HD-tDCS. Charlestown, Massachusetts also contributes to advancements in fibromyalgia care through 3 active trials investigating methods like Active tDCS and Tai Chi. These cities provide individuals suffering from fibromyalgia access to promising clinical trials that may offer new treatment options for improved quality of life.

Which are the top treatments for fibromyalgia being explored in clinical trials?

Fibromyalgia research is constantly evolving, with several promising treatments under exploration in clinical trials. The top contenders include exercise, actively being studied in two ongoing trials and a total of seven fibromyalgia trials since its initial listing in 2002. Another noteworthy option is active rTMS (repetitive transcranial magnetic stimulation), currently involved in one active trial along with a single all-time fibromyalgia trial since its first listing in 2012. Also showing potential is D-Cycloserine, which has garnered interest with one active trial and an inaugural entry into the field just this year (2022). Additionally, researchers are examining the effects of a gluten-free diet on fibromyalgia symptoms through one current trial that marks its debut on the scene in 2021. These innovative approaches hold promise for improving the lives of individuals living with fibromyalgia worldwide.

What are the most recent clinical trials for fibromyalgia?

Recent clinical trials offer potential breakthroughs in the treatment of fibromyalgia. One study focuses on psychotherapy as a promising approach, aiming to provide relief and improved quality of life for individuals with this condition. Another trial investigates the use of metformin, a well-known medication used for diabetes management, as a potential treatment option for fibromyalgia symptoms. Additionally, researchers are exploring stellate ganglion block therapy and D-Cycloserine as alternative interventions that may alleviate pain associated with fibromyalgia. Furthermore, TNX-102 SL is being studied in phase 3 trials to evaluate its effectiveness in managing symptoms related to fibromyalgia. With these innovative investigations underway, hope shines bright for individuals affected by fibromyalgia seeking effective therapies.

What fibromyalgia clinical trials were recently completed?

Several recent clinical trials have made significant strides in the field of fibromyalgia, offering hope for improved treatments. In June 2021, Virios Therapeutics completed a trial investigating IMC-1 as a potential therapy. Duke University's July 2020 trial explored Galcanezumab's efficacy in managing this complex condition. Aptinyx concluded their NYX-2925 study in November 2019 with promising results. Additionally, Weill Medical College of Cornell University and the University of Alabama at Birmingham conducted trials on Botulinum toxin type A (August 2018) and Dextromethorphan (June 2018), respectively, further contributing to our understanding of fibromyalgia treatment options. These advancements reflect ongoing efforts to address the challenges faced by individuals living with fibromyalgia.